Latest Shareholder Engagement News

BKI Investment Company Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.039 per share and providing key details on its Dividend Reinvestment Plan (DRP).

Auswide Bank’s acquisition by MyState Bank has reached a key milestone with the scheme of arrangement now legally effective, triggering a suspension of Auswide’s shares and setting the stage for shareholder transitions.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

Wellnex Life Limited has initiated a $22.1 million entitlement offer priced at $0.65 per share, coinciding with its proposed dual listing on the London Stock Exchange's AIM market, driven by strong UK institutional interest.

CAR Group Limited has announced a semi-annual ordinary dividend of AUD 0.385 per share, partially franked at 50%, payable in April 2025. Shareholders can opt into a Dividend Reinvestment Plan with no discount, reflecting steady shareholder returns.

WA Kaolin Limited has announced a fully underwritten pro-rata accelerated non-renounceable rights offer to raise approximately $7 million, aiming to bolster working capital and support production ramp-up at its Wickepin operations.

Whitebark Energy has locked in a $2 million placement to fund its acquisition of King Energy, positioning itself at the forefront of Australia's emerging white hydrogen and helium sectors.

Cosmos Exploration has raised A$1.25 million through an oversubscribed placement to support its strategic option agreement to acquire EAU Lithium, positioning itself deeper in Bolivia’s lithium-rich Triangle.

Pinnacle Investment Management Group has announced a 33-cent per share dividend for the half-year ending December 2024, offering shareholders a fully franked payout option and a Dividend Reinvestment Plan.

Xref Limited shareholders convened to vote on SEEK Limited’s proposed $0.218 per share acquisition, representing a substantial premium over recent trading prices. The outcome hinges on shareholder and court approval, marking a pivotal moment for the software company’s future.

Medlab Clinical reports a near-empty cash balance and zero receipts in Q2 2025, while actively pursuing a business acquisition ahead of its ASX removal date.

Bryah Resources has locked in $1.1 million through a two-tranche placement to fund its copper exploration efforts in the Bryah Basin and support ongoing business development.